secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001104659-25-073338
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade sells passenger division to Joby for up to $125M; to rebrand as Strata
----------------------------------------------------------------------------

- Up to $125M consideration (cash or Joby stock): $90M at close plus up to $35M earnout tied to performance and retention.
- Blade's medical division remains public and rebrands as Strata, focusing on contractual medical logistics and organ transport.
- CEO Rob Wiesenthal joins Joby as CEO of Blade unit, becomes Chairman of Strata; co-CEOs Tomkiel and Heyburn lead Strata.
- Transaction expected to be Adjusted EBITDA and FCF neutral; $7M in annual corporate cost efficiencies identified.
- Expected close in coming weeks; Blade's Passenger business includes US/Europe operations and the Blade brand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000110465925073338/0001104659-25-073338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000110465925073338/tm2522427d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-073338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer